Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657355 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users
A Phase 1 study, sponsored by Idorsia Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 63
- Enrollment target
NCT03657355 is a Phase 1 study that has completed, run by Idorsia Pharmaceuticals. The registered enrollment target is 63 participants.
The verdict
NCT03657355, a Phase 1 study, has completed, sponsored by Idorsia Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
This placebo- and active controlled study will investigate the abuse potential of ACT-541468 in healthy recreational drug users
Interventions
- DRUG Placebo
- DRUG Suvorexant
- DRUG Zolpidem
- DRUG ACT-541468
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-09-07 |
| Est. Completion | 2019-08-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03657355
The ClinicalTrials.gov registry entry for NCT03657355 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Idorsia Pharmaceuticals, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03657355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03657355 about?
NCT03657355 is a clinical study titled "Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users". This placebo- and active controlled study will investigate the abuse potential of ACT-541468 in healthy recreational drug users
What is the current status of trial NCT03657355?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 63 participants. The study started on 2018-09-07. Estimated completion is 2019-08-08.
What interventions are being tested in trial NCT03657355?
The interventions under investigation include: Placebo (DRUG), Suvorexant (DRUG), Zolpidem (DRUG), ACT-541468 (DRUG).
Who is sponsoring clinical trial NCT03657355?
This trial is sponsored by Idorsia Pharmaceuticals, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.